Melissa Krebs, CEO and Founder of GelSana, was honored to … Read More
GelSana Attends Diabetic Foot Conference (DF Con) in Los Angeles, September 2022!
GelSana attended Diabetic Foot Conference (DF Con) in sunny Los … Read More
GelSana Presents at Colorado BioScience Association Investor and Partnering Conference in Vail, CO, September 2022
GelSana was thrilled to be selected as one of the … Read More
GelSana Wins at the TechConnect World Innovation Conference 2022 Medical Innovation Challenge!
GelSana Therapeutics was selected to participate in the TechConnect World … Read More
GelSana Takes First Place at the 2022 Montfort College of Business Entrepreneurial Challenge
The University of Northern Colorado’s Monfort College of Business has announced the … Read More
GelSana awarded an Advanced Industries Accelerator grant
The Advanced Industries Accelerator (AIA) Program announced that 22 Colorado companies and … Read More
Colorado BioScience Association Highlights Health Innovators at Innovation Forward: Forum + Awards Celebration
LightDeck Diagnostics Named Company of the Year, Artisan Bio Honored … Read More
Innosphere Ventures Fund leads investment into bioscience company, GelSana Therapeutics
GelSana receives seed round investment to advance novel wound healing … Read More
GelSana Therapeutics, completes SBDC’s first-ever virtual Tech Venture Accelerator for Women
DENVER — Yesterday, the Colorado Small Business Development Center (SBDC) Network’s statewide TechSource … Read More
Innosphere Ventures “Funded in Colorado” episode with founder & CEO of GelSana Therapeutics, Melissa Krebs, PhD
In this “Funded in Colorado” episode, Innosphere’s CEO Mike Freeman … Read More